Discussions List
5
LIKES
1
REPLIES
74
VIEWS
8
LIKES
8
REPLIES
182
VIEWS
[WSRP26] Modeling dosing regimens with pharmacokinetic models for personalized glibenclamide therapy
5
LIKES
1
REPLIES
344
VIEWS
1
LIKES
4
REPLIES
298
VIEWS
Why can't the powerful Reduce and Solve functions handle this type of parametric inequality problem?
1
LIKES
4
REPLIES
324
VIEWS
0
LIKES
6
REPLIES
3.6K
VIEWS
2
LIKES
1
REPLIES
437
VIEWS
5
LIKES
1
REPLIES
632
VIEWS
6
LIKES
3
REPLIES
633
VIEWS
8
LIKES
2
REPLIES
2.7K
VIEWS
9
LIKES
4
REPLIES
1.3K
VIEWS
13
LIKES
8
REPLIES
3.6K
VIEWS
4
LIKES
6
REPLIES
1.1K
VIEWS
5
LIKES
7
REPLIES
906
VIEWS
0
LIKES
2
REPLIES
477
VIEWS
3
LIKES
4
REPLIES
1.6K
VIEWS
0
LIKES
0
REPLIES
330
VIEWS
0
LIKES
0
REPLIES
322
VIEWS
1
LIKES
4
REPLIES
780
VIEWS
0
LIKES
0
REPLIES
788
VIEWS